The FDA has approved Bayer’s gadobutrol (Gadavist) injection for use in cardiac MRI, making it the first contrast agent approved for the imaging technique, according to a statement from Bayer.

CMS revealed details for their newly proposed alternative payment model for radiation oncology on July 10. The American Society of Radiation Oncology (ASTRO) believes the model, with adjustments, "will incentivize higher quality, more convenient radiation treatments for patients and support their journey toward a cure."

A novel PET radiotracer can help identify changes in the brain’s grey matter that may be indicative of progressive multiple sclerosis (MS), according to a pilot study published in the July issue of Neurology: Neuroimmunology & Neuroinflammation.

Breast cancer screening using digital breast tomosynthesis has risen rapidly in the United States, but that isn’t the case in all regions or across all institutions, according to a new study published in Current Problems in Diagnostic Radiology.

Contrast-enhanced spectral mammography (CESM) can be a helpful method to screen for postoperative breast cancer when paired with traditional mammography, according to research published July 6 in Clinical Radiology.

Dynamic contrast-enhanced (DCE) MRI can help measure the permeability of the blood-brain barrier (BBB) in areas of the brain associated with migraines, potentially providing insight into the debilitating headaches and other neurovascular disorders.

A deep neural network platform can help radiologists detect abdominal aortic aneurysms (AAAs) on CT images, and is especially helpful in clinically challenging cases, according to research presented at the SIIM annual conference.

A higher level of background parenchymal enhancement (BPE) measured during breast MRI is associated with the presence of breast cancer in women at high risk of breast cancer but not in women with average risk, according to a new study.